thejapantimes, to Japan
@thejapantimes@mastodon.social avatar

The government has created a plan to overhaul a system allowing foods to be labeled as having specific functions on health, following Kobayashi Pharmaceutical's beni kо̄ji scandal. https://www.japantimes.co.jp/news/2024/05/31/japan/functional-foods/ #japan #kobayashipharmaceutical #pharmaceuticals #food #mhlw

thejapantimes, to Japan
@thejapantimes@mastodon.social avatar

A diabetes drug has been found to eliminate senescent cells — which accumulate with age and contribute to hardening of the arteries and other diseases — in mice, paving the way for research on aging-related diseases, researchers at a Tokyo university say. https://www.japantimes.co.jp/news/2024/05/31/japan/science-health/diabetes-drug-aging/

thejapantimes, to Japan
@thejapantimes@mastodon.social avatar

Two more unexpected compounds have been detected from Kobayashi Pharmaceutical's supplements containing beni kо̄ji (red fermented rice), health ministry officials said Tuesday. https://www.japantimes.co.jp/news/2024/05/29/japan/beni-koji-compounds/

thejapantimes, to Japan
@thejapantimes@mastodon.social avatar

A health ministry panel is urging small drugmakers to merge with their bigger counterparts to ensure a stable supply of generic drugs in Japan amid an ongoing shortage. https://www.japantimes.co.jp/news/2024/05/23/japan/science-health/japan-generic-drugs/ #japan #sciencehealth #manufacturing #pharmaceuticals #medicine #mhlw

thejapantimes, to Japan
@thejapantimes@mastodon.social avatar

Japan was once a strong player in the field of new drug development, but has fallen behind in recent years. A new proposal hopes to change that by accelerating local efforts. https://www.japantimes.co.jp/news/2024/05/22/japan/science-health/generic-drugs-supply/

thejapantimes, to Japan
@thejapantimes@mastodon.social avatar

Japan has trialed over-the-counter sales of the morning-after pill without a doctor's prescription, and 80% of buyers have said they would want to buy the medication that way again. https://www.japantimes.co.jp/news/2024/05/20/japan/science-health/morning-after-pills-survey/

thejapantimes, to Japan
@thejapantimes@mastodon.social avatar

A drug to treat distal myopathy has recently been approved for the first time worldwide, for use in Japan, following clinical trials at Tohoku University in Sendai. https://www.japantimes.co.jp/news/2024/05/20/japan/science-health/distal-myopathy-drug-approved/

thejapantimes, to business
@thejapantimes@mastodon.social avatar

Blackstone is working with the management of I’rom Group to take the Japanese pharmaceutical services company private. https://www.japantimes.co.jp/business/2024/05/13/companies/blackstone-drug-trial-firm-private/

thejapantimes, to Japan
@thejapantimes@mastodon.social avatar

A Japanese government panel is reviewing the "functional food label" system in the wake of Kobayashi Pharmaceutical's beni koji (red yeast rice) scandal. https://www.japantimes.co.jp/news/2024/04/30/japan/science-health/functional-food-label-review/

thejapantimes, to Japan
@thejapantimes@mastodon.social avatar

Kobayashi Pharmaceutical will pay the medical bills of people who became ill after taking its troubled beni kōji fermented red rice supplements, the firm has announced. https://www.japantimes.co.jp/news/2024/04/26/japan/science-health/kobayashi-pharma-medical-bills/

thejapantimes, to Japan
@thejapantimes@mastodon.social avatar

More unexpected compounds have been found in some of Kobayashi Pharmaceutical's beni kōji (red yeast rice) supplements that are allegedly behind a series of health problems. https://www.japantimes.co.jp/news/2024/04/20/japan/science-health/kobayashi-pharma-beni-koji-more-compounds/

thejapantimes, to Japan
@thejapantimes@mastodon.social avatar

Eighteen products with the “functional food” label in Japan had received over 110 reports from medical professionals as having caused some level of health damage among their users, a survey showed. https://www.japantimes.co.jp/news/2024/04/12/japan/science-health/funcitonal-food-product-survey/

thejapantimes, to Japan
@thejapantimes@mastodon.social avatar

The scandal over Kobayashi Pharmaceutical’s red yeast rice supplements has put a spotlight on regulatory inadequacies that prevented Japan from swiftly addressing concerns related to foods with health-enhancing claims. https://www.japantimes.co.jp/news/2024/04/12/japan/science-health/japan-health-food-regulations/

thejapantimes, to Japan
@thejapantimes@mastodon.social avatar

Kobayashi Pharmaceutical’s beni kōji scandal has prompted growing repercussions in Taiwan, where health authorities have announced steps that will help consumers get refunds from the Japanese drugmaker. https://www.japantimes.co.jp/news/2024/04/11/japan/science-health/taiwan-kobayashi-pharma-pills/

thejapantimes, to Japan
@thejapantimes@mastodon.social avatar

Kidney doctors nationwide have received health complaints from 95 people who took Kobayashi Pharmaceutical’s beni kōji red yeast rice supplements, the health ministry has said. https://www.japantimes.co.jp/news/2024/04/09/japan/science-health/health-ministry-beni-koji-presser/

thejapantimes, to Japan
@thejapantimes@mastodon.social avatar

The health ministry and Osaka city government conducted hearings at the Kobayashi Pharmaceutical headquarters over dangers possibly linked to its supplements containing beni kо̄ji red fermented rice. https://www.japantimes.co.jp/news/2024/04/07/japan/crime-legal/government-hearings-kobayashi-pharmaceutical/ #japan #crimelegal #kobayashipharmaceutical #pharmaceuticals #osaka #health #mhlw

thejapantimes, to Japan
@thejapantimes@mastodon.social avatar

Nearly two weeks have passed since Kobayashi Pharmaceutical first reported health concerns over its red yeast rice supplements — but tracking down its tainted products in the supply chain is proving to be extremely difficult. https://www.japantimes.co.jp/news/2024/04/04/japan/science-health/beni-koji-supply-chain/

thejapantimes, to Japan
@thejapantimes@mastodon.social avatar

Puberulic acid, a natural compound derived from blue mold, has been detected in Kobayashi Pharmaceutical's beni kо̄ji supplements, but the substance's effect on the human body is still unclear. https://www.japantimes.co.jp/news/2024/04/04/japan/science-health/kobayashi-pharmaceutical-health-damage/

thejapantimes, to Japan
@thejapantimes@mastodon.social avatar

The number of people who have been hospitalized over health issues associated with Kobayashi Pharmaceutical's supplement products containing beni koji came to 166 as of Monday. https://www.japantimes.co.jp/news/2024/04/03/japan/society/beni-koji-more-hospitalized/

thejapantimes, to Japan
@thejapantimes@mastodon.social avatar

Kobayashi Pharmaceutical's dietary supplements at the center of an expanding health scare have now been linked to at least 157 hospitalizations, a health ministry official said Tuesday. https://www.japantimes.co.jp/news/2024/04/02/japan/science-health/kobayashi-pharmaceutical-more-hospitalizations/

thejapantimes, to Japan
@thejapantimes@mastodon.social avatar

The health ministry and local authorities on Saturday inspected a Kobayashi Pharmaceutical factory in Osaka following reports of deaths and hospitalizations possibly linked to its red yeast rice dietary supplements. https://www.japantimes.co.jp/news/2024/03/30/japan/science-health/kobayashi-pharma-factory-inspected/

thejapantimes, to Japan
@thejapantimes@mastodon.social avatar

Scandal-hit Kobayashi Pharmaceutical said on Friday that a chemical compound naturally made from blue mold may have been the cause of the health damage linked to its beni kо̄ji (red yeast rice) dietary supplements. https://www.japantimes.co.jp/news/2024/03/29/japan/science-health/kobayashi-pharma-apologizes-in-presser/

thejapantimes, to Japan
@thejapantimes@mastodon.social avatar

Kobayashi Pharmaceutical’s growing scandal over its red yeast supplements has reignited a debate on Japan’s “functional food” labels. https://www.japantimes.co.jp/news/2024/03/29/japan/science-health/japan-functional-food-label-under-scrutiny/

thejapantimes, to Japan
@thejapantimes@mastodon.social avatar

Kobayashi Pharmaceutical said Friday that it has confirmed a fifth death linked to its beni kо̄ji red yeast rice dietary supplements. https://www.japantimes.co.jp/news/2024/03/29/japan/kobayashi-pharma-confirms-fifth-death/

  • All
  • Subscribed
  • Moderated
  • Favorites
  • •
  • megavids
  • thenastyranch
  • rosin
  • GTA5RPClips
  • osvaldo12
  • love
  • Youngstown
  • slotface
  • khanakhh
  • everett
  • kavyap
  • mdbf
  • DreamBathrooms
  • ngwrru68w68
  • provamag3
  • magazineikmin
  • InstantRegret
  • normalnudes
  • tacticalgear
  • cubers
  • ethstaker
  • modclub
  • cisconetworking
  • Durango
  • anitta
  • Leos
  • tester
  • JUstTest
  • All magazines
    •